Clinical features of flail arm syndrome [1]

Muscle and Nerve

Volumn 23, Issue 4, 2000, Pages 646-647

  Couratier, Philippe ^a   Truong, CaoTri ^a   Khalil, Mohamed ^a   Devière, Franck ^a   Vallat, Jean Michel ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FLAIL ARM SYNDROME; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; MAJOR CLINICAL STUDY; MALE; MUSCLE WEAKNESS; PRIORITY JOURNAL; PROGNOSIS; RESPIRATORY FAILURE; SURVIVAL; SYMPTOMATOLOGY; SYNDROME DELINEATION;

DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MOTOR NEURON DISEASE;

EID: 0034068210     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4598(200004)23:4<646::AID-MUS26>3.0.CO;2-E     Document Type: Letter

References (4)

1. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994;124:96-107.
2. Gowers WR. A manual of diseases of the nervous system: spinal cord and nerves, volume I. London: Churchill; 1888. p 356-381.
3. Hu MTM, Ellis CM, Al-Chalabi A, Leigh PN, Shaw CE. Flail arm syndrome: a distinctive variant of amyotrophic lateral sclerosis. J Neurol Neurosurg Psychiatry 1998;65:950-951.
4. Lacomblez L, Bensimon G, Leigh PN, Guillet P, Meininger V. Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II. Lancet 1996;347:1425-1431.